Ulupreneurs in the news

Zum
A TechCrunch article highlighted Zum CEO Ritu Naryan as one of the featured speakers at TC Disrupt 2023.

Vaxess
Endpoints News headlined Astrazeneca’s partnership with Vaxess to develop skin patch mRNA vaccines for flu pandemic.

Sequel
New York Post and several outlets featured FDA approval of Sequel’s newly designed tampon.

Sequel
The Wall Street Journal and several other outlets featured FDA approval of Sequel’s newly designed tampon.

Sequel
Fortune profiled Sequel’s CEO Amanda Calabrese and the firm’s efforts to take tampons to the next level.

LeadSales
TechCrunch profiled LeadSales’ targeting of LatAm conversation commerce in WhatsApp and their $3.7M raise.

Irrigreen
CBS News Minnesota featured Irrigreen in a piece about how homeowners can conserve water while irrigating their lawns.

Hey Jane
A Fortune article highlighted Hey Jane’s plans to expand beyond abortion services to provide other digital health treatments.

Genesis Therapeutics
The Wall Street Journal featured Genesis Therapeutics’ $200M Series B round, which will help the firm find drugs discovered with artificial intelligence and assist them in entering clinical trials.

Bridge
Geek Wire (and other outlets) headlined Bridge’s acquisition by Boundless, combining two immigration-focused startups.

Swing Education
CityBiz (and other outlets) headlined Swing Education’s $38M Series C raise to grow the pool of qualified substitute teachers and school district partners across the seven states and District of Columbia where Swing currently operates, and expand to new regions.

Parfait
The Today Show featured the Parfait team in an in-depth piece about their passion in revolutionizing the custom wig industry through AI.

Buzz Solutions
Forbes profiled Buzz Solutions and the firm’s work using AI to help protect the nation’s energy infrastructure and make it more efficient.